Quantres Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$314K Buy
+3,900
New +$319K 0.23% 119
2018
Q3
Sell
-23,700
Closed -$2.2M 202
2018
Q2
$2.2M Sell
23,700
-22,900
-49% -$2.24M 1.27% 14
2018
Q1
$4.41M Buy
+46,600
New +$5.12M 2.68% 7
2016
Q4
Sell
-14,800
Closed -$933K 151
2016
Q3
$933K Buy
+14,800
New +$958K 0.58% 61
2015
Q4
Sell
-83,700
Closed -$4.55M 119
2015
Q3
$4.55M Buy
+83,700
New +$5.45M 3.54% 3
2015
Q2
Sell
-28,000
Closed -$1.64M 158
2015
Q1
$1.64M Buy
28,000
+11,600
+71% +$701K 1.64% 17
2014
Q4
$1.07M Buy
+16,400
New +$1.03M 1.04% 29

Other funds holding ABBV

Quantres Asset Management's ABBV Position: Q1 2019 in Review

Quantres Asset Management opened a new position in AbbVie (ABBV) in Q1 2019: 3,900 shares worth $314K. The stake represents 0.23% of the portfolio and ranks #119 among its holdings. This is a return to the name: Quantres Asset Management previously reported a position in ABBV as recently as Q2 2018.

Quantres Asset Management first reported a position in ABBV in Q4 2014 and has held it in 7 quarters since. The position peaked at $4.55M in Q3 2015. 2,034 funds tracked by Wall St. Rank hold ABBV as of Q1 2019.

  • Quantres Asset Management held 3,900 shares of AbbVie worth $314K as of Q1 2019.
  • AbbVie was a new Quantres Asset Management position in Q1 2019.
  • AbbVie made up 0.23% of Quantres Asset Management's portfolio in Q1 2019, its #119 holding.
  • Quantres Asset Management first reported a position in AbbVie in Q4 2014 and has held it in 7 quarters since.
  • Quantres Asset Management's AbbVie position peaked at $4.55M in Q3 2015.
  • 2,034 funds tracked by Wall St. Rank held AbbVie as of Q1 2019.

Based on Quantres Asset Management's 13F filing for Q1 2019, filed 12 Apr 2019.